Tuberculosis Infection Clinical Trials

9 recruiting

Tuberculosis Infection Trials at a Glance

13 actively recruiting trials for tuberculosis infection are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Roma, Kampala, and Bandung. Lead sponsors running tuberculosis infection studies include Baylor College of Medicine, Beth Israel Deaconess Medical Center, and Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd..

Browse tuberculosis infection trials by phase

About Tuberculosis Infection Clinical Trials

Looking for clinical trials for Tuberculosis Infection? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tuberculosis Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tuberculosis Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2Phase 3

Shorter and Safer Treatment Regimens for Latent TB

Tuberculosis Infection, Latent
McGill University Health Centre/Research Institute of the McGill University Health Centre1,800 enrolled13 locationsNCT06498414
Recruiting
Not Applicable

Clinic-based Versus Hotspot-focused Active TB Case Finding

Tuberculosis, PulmonaryMycobacterium Tuberculosis Infection
Johns Hopkins University150,000 enrolled1 locationNCT05285202
Recruiting
Not Applicable

Window Prophylaxis for Pediatric Tuberculosis Prevention Trial

TuberculosisAdolescentChildren+3 more
Pontificia Universidad Catolica de Chile647 enrolled13 locationsNCT07086820
Recruiting
Phase 1

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

Pediatric HIV InfectionTuberculosis Infection
Brigham and Women's Hospital20 enrolled1 locationNCT05069688
Recruiting
Not Applicable

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

TuberculosisTuberculosis InfectionHIV Coinfection
Baylor College of Medicine6,500 enrolled5 locationsNCT05342064
Recruiting

Testing Health Workers At Risk to Advance Our Understanding of TB Infection

TuberculosisTuberculosis Infection
Beth Israel Deaconess Medical Center300 enrolled1 locationNCT06221488
Recruiting
Phase 3

Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

Latent Tuberculosis Infection
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.780 enrolled8 locationsNCT05899179
Recruiting

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Latent Tuberculosis InfectionTuberculosis
Huashan Hospital31,440 enrolled44 locationsNCT06033807
Recruiting

Effects of Tuberculosis Infection on Development and Function of the Placenta

Pregnancy RelatedTuberculosis InfectionPlacenta Diseases
Lund University500 enrolled1 locationNCT06352970
Recruiting
Not Applicable

Immunological Biomarkers in Tuberculosis Management

TuberculosisTuberculosis Infection
Hospices Civils de Lyon60 enrolled1 locationNCT04271397
Recruiting
Phase 1

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

Tuberculosis Infection
University of Zurich16 enrolled1 locationNCT05443178
Recruiting

Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age

Tuberculosis Infection
Meyer Children's Hospital IRCCS1,000 enrolled17 locationsNCT06289660
Recruiting

Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students

TuberculosisTuberculosis, PulmonaryTuberculosis Infection+2 more
Eleonora Nucera2,040 enrolled1 locationNCT05756582